Cancer is a disease of the whole organism, physical, mental and spiritual, even if still localized, i.e. without metastases. It is a proliferation of cells with unique trait: loss of normal controls that results in unregulated growth, lack of differentiation, local tissue invasion, and metastasis.
The growth of cancer is a regression from the differentiated cell to the non-differentiated cell, or from the adult to embryonic stage of development.
All higher organisms start their lives from one fertilized cell. As long as there is no connection to the blood, and thereby there is a lack of oxygen, cells of the developing embryo divide without differentiation. After nidation of the product of conception at morula stage in the endometrium, the oxygen supply develops, and that triggers the differentiation of the up until then uniform embryonic cells into specific tissues and organs (thereby launching the fetal stage of development).
Cancer is a regression to the ‘pre-nidation stage of division without differentiation’.
Disturbed relationship of Krebs cycle, normally providing 80% of energy supply for the human body, to the evolutionary ancient glycolysis, normally supplying only 20% of energy, is probably the most important cause of the regression of mature differentiated tissue into the immature, undifferentiated, embryonic, tissue of cancer. When the supply of energy via Krebs cycle drops to such a low level that certain part of the normal tissue begins to cover more than 20% of its energetic needs by glycolysis, that part of tissue switches back to the state of division without differentiation, as it was in the early embryonic stage, and such undifferentiated cells easily transform into malignant ones.
Cancer is a genetic disease on a somatic cell level
“Genetic mutations are largely responsible for the generation of cancer cells. These mutations alter the quantity or function of protein products encoded by growth-regulating genes that regulate cell division and DNA repair. Two major categories of mutated genes are oncogenes and tumor suppressor genes.
Oncogenes are abnormal forms of normal genes (proto-oncogenes) that regulate cell growth. Mutations of these genes may result in direct and continuous stimulation of the molecular biologic pathways that control cell growth and division. There are over 100 known oncogenes that contribute to human neoplastic transformation, e.g. ras gene encodes Ras protein, which regulates or signals cell division, but in 25% of human cancers it signals erroneously cells to divide even though they should not. Regulatory protein p53 prevents replication of damaged DNA in normal cells and promotes apoptosis (programmed cell death) in cells with abnormal DNA. Inactive or altered p53 allows cells with abnormal DNA to survive and divide. Mutations are passed to daughter cells, conferring a high probability of neoplastic transformation. The p53 gene is defective in many human cancers.
Oncogenes typically result from acquired somatic cell mutations secondary to point mutations from chemical carcinogens, gene amplifications or insertion of viral genetic elements into host DNA.
Tumor suppressor genes suppress normally the development of cancer by encoding for proteins that suppress cancer initiation and growth. They are inherent genes that play role in cell division and DNA repair, critical for detecting inappropriate growth signals in cells. If these genes become unable to function as a result of mutations, genetic mutations in other types of genes can proceed unchecked, leading to neoplastic transformation.
As with most genes, 2 alleles are present that encode for each tumor suppressor gene. A defective copy of one gene may be inherited, leaving a human being with only one functioning allele for the individual tumor suppressor gene. If an acquired mutation occurs in the other allele, the normal protective mechanisms of tumor suppressor gene are lost, and dysfunction of other protein products or DNA damage may escape unregulated, leading to cancer.”
All above quoted paragraphs are taken from ‘Merck Manual of Diagnosis and Therapy’, 18th edition, 2006, the ‘bible’ of pharmaceutical industry for physicians. Cancer is a genetic disease, but none of the cancer therapies described in ‘Merck Manual’ is aimed at the treatment of effects of acquired mutations, inactivation of oncogenes, or their reversal to normally functioning proto-oncogenes, or DNA repair of mutated tumor suppressor genes. Genetic manipulation by gene therapy is briefly mentioned. B5t not the fact that the sole method of gene therapy known to current medicine is the correct kind of fetal precursor cell transplantation. Animal fetal precursor cell transplantation used in human therapy for 85+ years has been used as a form of physiologic cell therapy for years. Father of this therapy, Prof.Dr. Paul Niehans, Bern, Switzerland, has published extensively on this subject. His inaugural speech in 1955 at his introduction into Papal Academy of Sciences in Vatican, the sole non-Catholic ever, was devoted to the subject of cancer prophylaxis by repeated cell transplantation therapies of aging people.
BCRO fetal precursor cell transplantation is one of three key components of 'Drs. V.N.M. Integrative Individualized Cancer Treatment Project'.
Cancerous tissue is an immature, developmentally regressed tissue. Biologically thinking cancer therapists believe that it is more rational to stimulate this developmentally regressed tissue and give it all support necessary for its re-maturation and re-differentiation, because only by differentiation it is possible to re-integrate the cancerous tissue back into the normal organization of the body.
Despite some success rate it appears illogical to aim the entire therapeutic effort at destruction of undifferentiated immature cancer cells with treatment methods that damage healthy tissue as well, including the immune system, seriously endanger life of the cancer patient, violate human rights of victims of this dreadful disease by causing pain and suffering for no medically justifiable reason.
Current usual approach of handling malignant solid tumor
Traditionally when a doctor detects a tumor which further down is diagnosed as malignant, the first thing that comes to mind is to refer the patient for surgery, therefore the surgeon makes the first move towards elimination of the malignancy; after the patient recovers from this he undergoes chemotherapy for several months, at the end of which radiotherapy on the surgical site is sometimes carried out or a form of hormone therapy.
The above described sequence of events usually fails to eradicate the malignancy which makes it come back either at the original site or distantly or both; treatment thereafter becomes palliative. The patient at this point has lost its chance to be free from the grip of the neoplasm.
The malignant tumor reaches far beyond its visible or perceptible confines in the form of microscopic spread, therefore current criteria for surgical margins becomes non-operant (unless tumor is confined to precise limits), therefore, it is imperative to eliminate the microscopic spread in anticipation of surgery. For this a rather low dose of radiation with enhanced biological effect is administered to the tumor, its surroundings and the regional lymphatic areas; the effect of this can be magnified by the use of radio-sensitizing agents (of the cytostatic type) administered concomitantly also at low dose.
The purpose of such preparation is not to eliminate the tumor, but rather cleanse the surrounding area from the microscopic disease and confine the tumor to a smaller mass; it also accomplishes retraction of the tumor from important structures such as blood vessels, nerves, bone, organs, etc., facilitating its removal. This would be the equivalent to sterilizing the area.
From the above explanation the steps to follow in order to attempt eradication of a solid malignancy have to be re-structured.
Cyto-reduction can be accomplished by a combination of low-dose chemo/radiation, followed by surgery, then a cytostatic follow-up at substandard doses. Hormone therapy (when indicated) should be started from the beginning of treatment.
Administering a subsequent (smaller) dose of radiation to the same area(s) four weeks after surgery will effectively prevent local recurrence from surgical seeding.
With the use of the above general approach, we are proud to state that we have not seen local recurrence from breast carcinoma in the last 30 plus years.
In addition to the above general approach other modifications have been implemented to maximize results and minimize side effects. The incorporation of allied modalities has enabled us to overcome well known resiliencies on some types of malignancies, especially those considered therapeutically hopeless.
For example excellent results are obtained for most sarcomas in all stages, using only 20% or less of the usual chemotherapy dose, with remissions lasting several years while on non-toxic supplemental programs.
Pancreatic carcinoma, another feared recalcitrant neoplasm when deemed inoperable, can be tamed for months on a mild cytostatic agent aided by alternate natural products.
Non-Hodgkin’s Lymphomas (stages III and IV) can be brought into remission using a mild 2/3 substandard chemotherapy/radiation program and kept in that state for years without any further cytostatic therapy.
Prostatic carcinoma (any stage) can be placed and maintained in remission or asymptomatic for years. Favorable response usually surpasses 90%.
Most early stage solid tumor malignancies will enter remission and stay that way for well over 5 years to be considered eradicated after using the above general approach, typically of this are carcinomas of the head and neck, and early rectal and breast carcinomas.
The outstanding advantage of this general approach and allied method developed and used by our group in the last 30 years , is the high success rate to achieve the goal and the low side effects on the patient.
With regards to the treatment of cancers other than those mentioned in the early stages, our approach would render better results than the standard ones, but if the disease has already spread, results may not be better, except that patients would not go through much suffering with side effects; for example, we have had good results with early stages of non-small cell ca., but not with small cell type; as for primary brain malignancies, we have the advantage that in most early cases surgery would be unnecessary. We have had good success in stalling the progression of the advanced inoperable melanoma by doing immunotherapy with BCG, Interferon and other vaccines and fetal precursor cell transplantation.
Biological cancer treatment consists of the following steps individualized for each patient:
1/ Precursor fetal cell transplantation, that directs de-differentiated cancerous cells back toward natural re-maturation. The effect of BCRO fetal precursor cell transplantation is tumor-specific and dose-dependent, i.e. primary malignant cell determines the choice of cell type to be used for fetal precursor cell transplantation.
2/ Fetal precursor cell transplantation for direct stimulation of the immune system that has failed its function of immune surveillance, usually as a result of previous orthodox cancer treatments, (as it is virtually impossible today that the cancer patient seeks help of the practitioner of biologic cancer therapy first).
3/ Implantation of cytotrophoblastic cells of chorionic villi eliminates blocking factors from the blood of cancer patient.
4/ Ecological, nutritional and lifestyle modifications, elimination of all noxious elements, diet according to the genetic nutritional type of each patient, use of digestive pancreatic enzymes before each meal, optimal lifestyle, etc.
Avoidance of a/ simple sugars (‘cancer fertilizer’),
b/ artificial sweeteners made of aspartame,
c/ acidic internal environment of the body, by not consuming any red meat, especially not past 13:00, drinking solely alkaline mineral water and consuming copious quantities of baking soda, as well getting sodium bicarbonate infusions daily for several weeks,
d/ hypoxic internal environment of the body is mandatory, as well as regular ingestion of
- cancer fighting foods
- cancer fighting herbal supplements
- essential omega 3 fatty acids,
- vitamins, especially vitamin D3, and
- minerals, especially selenium and zinc.
Dr. William D. Kelley, who cured his own terminal pancreatic cancer at the age of 36 by a program of correct nutrition and supplementation of pancreatic digestive enzymes, and vitamins and minerals as co-enzymes, has taught for decades that we should lower the protein intake, and in particular avoid eating protein past 13:00. As is well known to U.S. authorities his success rate with treatment of 33, 000 similar patients was 90%. After the age of 45 we all should take in the afternoon a supplement of all (!) pancreatic enzymes as well as multi-vitamin/multi-mineral formula.
W. D. Kelley divides people into eleven metabolic types, from slow-oxidizing vegetarians at one end to fast-oxidizing carnivores at the opposite end of the Gaussian curve. Each person has different nutritional needs as well as different utilization of food.
Each of the eleven metabolic types must follow a different nutritional program. Kelley devised a detailed questionnaire, based on which anybody can determine his/her metabolic type and thereby a correct nutritional program.
This approach is rational. If we would force real vegetarians to eat red meat every day, they would suffer a serious sickness in no time. Similarly if Eskimos, who eat only animal protein and fat, would have to eat vegetarian food only, they would become severely ill within weeks. For those people who are in the remaining nine metabolic types in between these two extremes, it is mandatory to adhere to the recommended foods, if they want to stay healthy.
5/ Oxygenation, to increase the participation of Krebs cycle in providing for the energy needs up to the normal 80% level, and that includes physical activity and exercise, various forms of oxygen therapy, including hyperbaric oxygen, oral hydrogen peroxide, as well as an improvement of enzyme function of all metabolic pathways, including of the respiratory electron transport chain in mitochondria, by fetal precursor cell transplantation, along with oral intake of all co-enzymes required by the body metabolism.
Simply inhaling oxygen is not enough. Only 15% of oxygen you inhale is absorbed into the blood stream. Oxygen must enter the blood, and the blood, in turn, has to deliver oxygen to each cell of all tissues and organs of the body, and each cell must be able to receive the oxygen delivered by the blood. This would raise tissue oxygen levels, kill microorganisms and defective tissue cells, enable healthy cells to survive and multiply more rapidly – and ultimately create a stronger immune system.
In 1931 O. Warburg won the Nobel Prize in Physiology for proving that viruses cannot proliferate or exist in an environment with high levels of oxygen. That’s because viruses are anaerobic, which means that they occur and thrive in the absence of oxygen. O. Warburg said: ‘Deprive a cell of 35% of its oxygen for 48 hours and it may become cancerous. … The prime cause of cancer is insufficient oxygen at the cellular level, and … cancer cells cannot survive in a high oxygen environment.”
Louis Pasteur recanted his germ theory on his deathbed, stating “The microbe is nothing. The terrain is everything.” A weakened or suppressed state of the immune system occurs only when the human body lacks oxygen, thereby allowing pathogenic bacteria to breed.
R. Wirchow, the father of pathology, said a t the end of his life: “If I could live my life over again, I would devote it to proving that germs seek their natural habitat, diseased tissue, rather than being the cause of diseased tissue; e.g. mosquitoes seek the stagnant water, but do not cause the pool to become stagnant.” Likewise, germs, bacteria, viruses and pathogens, do not cause disease, but rather seek out environments where they can thrive the best – and that is in oxygen-deprived bodies.
There have been countless studies proving conclusively that increased oxygenation brings about the destruction of viruses. Cancerous tumors shrink when put into contact with oxygen. Not only cancer cells but almost all toxins, bacteria, viruses and disease microorganisms, are oxidized and killed in high oxygen environments. We know that cancer and other disease-causing cells simply cannot survive and thrive in the body that is oxygen-rich.
6/ In some instances, selective stimulation of T-cell activity by transfer factor, implantation of dendritic cells ordendritic cell vaccines, passive lymphocyte transfer, etc.
7/ In emergency situations, lowering the cancer cell count by plasmapheresis: the fewer cancer cells are present in the body of a patient, the greater is the chance of success of fetal precursor cell transplantation treatment.
BCRO fetal precursor cell transplantation has to be repeated at different intervals, i.e. therapeutic program is individualized to fit the disease condition of a patient.
The biological cancer therapy must be combined with modified orthodox treatment of cancer that serves the purpose of cyto-reduction of cancer cell mass:
1/ Surgery is limited strictly to the excision of the necrotic center of the tumor. This ‘debulking’ is quite important at the beginning of cancer treatment to get rid of the ‘biologically dead’ tissue, that is indeed dead if you would measure its electromagnetic field. The dead tissue is beyond the reach of any treatment. Radical excision with wide margins of healthy tissue must be avoided. It should be noted that old experts of German zellentherapie believed that cancerous growth of stomach, pancreas, gallbladder and prostate, should never be operated upon.
Fetal cell transplantation is recommended even in cases of inoperable cancer as it significantly improves the tolerance of cytostatica, inhibits the formation of metastases postoperatively, or decreases their size up to a complete regression.
2/ Radiation must be avoided except when ‘debulking’ is necessary in cases of the advanced dissemination of cancer of hematopoietic and lymphatic systems, when the diagnosis was established too late and spread of cancerous cells became massive, so that the normal cells of these, and other tissues, are ‘suffocated’ by cancerous cells.
Radiation treatment decreases the effectiveness of fetal precursor cell transplantation against cancer, but not as much as chemotherapy.
Treatment of cancer by fetal precursor cell transplantation prevents the weakening of the immune system caused by chemotherapy and radiotherapy via its immunostimulatory effect.
3/ Chemotherapy must be used in lower dosage that does not destroy immune system and other healthy tissues, and does not intoxicate the patient. During chemotherapy the anti-cancer effect of fetal precursor cell transplantation is noticeably decreased, particularly of cytotrophoblastic cells. After high dose chemotherap, BCRO fetal precursor cell transplantation should be delayed for 4 – 6 weeks.
There is a growing number of reports in peer reviewed journals from the leading oncologic centers on the success of new therapeutic protocols that encompass conservative cancer surgery, radiation therapy limited to a total of 30 Gy, chemotherapy dosage decreased by 70%, and fetal precursor cell transplantation.
Today there are hardly any patients with cancer that received treatment in accordance with above rules. All cancer patients that have ever had fetal precursor cell transplantation, have had it after the standard oncologic treatment failed to control their disease and they began to desperately look for something else to save their life. Majority of such patients are still undergoing some form of standard oncologic treatment at the time of their consultation with cell transplantologist.
It is difficult to combine the traditional (full ‘slash and kill’) dose of orthodox cancer therapy with the biological treatment:
a/ Fetal cell transplantation must not be used while the patient is taking chemotherapy up until the effect of medications subsides, or when the patient is scheduled to be treated by chemotherapy before the implantation of fetal precursor cell transplants, because cytostatica damage implanted fetal precursor cell transplants.
b/ For the same reason there must be an interval of 2 to 4 weeks between the implantation of BCRO fetal precursor cell transplants and beginning of radiation treatment, or between the completion of irradiation and implantation of fetal precursor cell transplants.
In this situation it is extremely difficult to create a workable treatment scheme, particularly for patients with advanced cancer, or those with complications of cell destructive therapies.
Modified orthodox treatment of cancer that serves the purpose of cyto-reduction of cancer cell mass is the second key component of ‘Drs. V.N.M. Integrated Individualized Cancer Treatment Project’.
Scientific basis of the first component of ‘Drs. V.N.M. Integrative Individualized Cancer Treatment Project’.
Julius Cohnheim, an assistant of Rudolf Virchow, the father of modern pathology, proposed in 1877 an embryonic theory of cancer whereby cancerous tumor originated from small clusters of embryonic cells that remained unchanged during the development of an organism. In other words, cancer cell is an embryonic cell deprived of an ability to participate in normal embryogenesis, or ‘oncogenesis is a blocked ontogenesis’.
In 1902 John Beard published in Lancet "Embryological Aspects and Etiology of Carcinoma", proposing his ‘trophoblastic theory of cancer’, whereby cancer is a trophoblast tissue that deviated from the proper development by departing from the placenta and dispersing throughout the body. Such tissue could originate not only from germ cells but also from somatic cells with de-repressed genes.
Similarities between the development of cancer and embryonic development have given growing support to the trophoblastic theory of cancer.
1/ Malignant tumors synthesize and release into blood many embryo-specific and trophoblast-specific proteins, e.g. a-fetoprotein, carcino-embryonic antigen (CEA), enzymes typical of embryo, many trophoblast-specific hormones , e.g. chorionic gonadotropin (HCG), etc., and immunosuppressive substances that defend the cancer against the host immune system.
2/ Organism’s immune response to cancer antigens is remarkably similar to its response to the embryonic and trophoblastic antigens.
3/ There are many reports of cross-reaction between embryonic/trophoblastic and cancer antigens. Antigens of the developing embryo and trophoblast have exactly the same properties.
4/ Cancer is a ‘pathologic embryo’, which copies the immune reactions occurring during pregnancy.
5/ Biochemical similarities of cancer and embryonic cells have been recognized for many years.
6/ Cytoplasm of cancer cells has an embryonic type of organization.
7/ Cancer cells copy the key biologic mechanism, i.e. ability to reproduce.
8/ Embryo, trophoblast and cancer cells, utilize the same mechanisms to avoid immunologic recognition and lysis by the effector cells of immune system.
9/ Malignant properties of cancerous tumors, i.e. invasive growth, unrestricted rapid mitoses, metastases, are all natural functional characteristics of normal trophoblast development. Trophoblast components are inevitable for any malignant tumor.
Task of treatment of cancer is to create the type and level of immune reactions characteristic of a spontaneous abortion. How to accomplish it in clinical practice?
Pregnancy is a state of natural parabiosis, i.e. tolerance between two genetically different organisms. Establishment of normal pregnancy requires not only mother’s immunologic tolerance to embryo but an active immunological recognition of paternally inherited proteins in the products of conception. The recognition of MHC and MHC-like paternal antigens during pregnancy stimulates the suppressor immunity but not cytotoxic effector immunity. So recognition of foreign antigens is not accompanied by elimination, but by a tolerance of genetically different cells. The more active is such recognition, the stronger the suppression of rejection. Without this, the survival of trophoblast and placenta, and existence of pregnancy-specific immunosuppressive mechanism, are impossible. A deficiency of immunosuppressive mechanism leads to the rejection of fetus, and rejection of cancer as well.
Cancer can be regarded as a disease of immunosuppressive reaction in the organism. Normally, immunosuppression, as after organ transplantation, not only suppresses the rejection, it increases the risk of cancer development. Or, pregnancy protects to a degree against carcinogenesis. And, appearance of cancer in human fetuses or newborns is extremely rare.
Immunosuppression during pregnancy is accomplished through the joint activity of maternal lymphocytes and humoral products of fetal and placental origin. Even though the fetal portion of placenta is not genetically identical to the maternal portion, placenta is not ever rejected by mother. Paternal MHC antigens of fetal portion of placenta are not targets for maternal lymphocytes.
There are tumor products recognized by the host’s immune system that do not cause tumor rejection. It is due to induction of suppressor T-lymphocytes, decreased level of T-helpers, and autologous serum blocking factors in cancer patients. Recognition of tumor antigens by the patient’s immune system occurs simultaneously with suppression of effector mechanisms of cell immunity by serum blocking factors. Cancer is a pathologic process capable of neutralizing any number of cytotoxic lymphocytes.
Therapeutic anti-cancer effect can be achieved by inhibition of immunosuppressive properties of embryo-like functions of malignant cells. In other words, besides a general augmentation of the host’s immune system, which may weaken to the level of a total anergy in the patients with advanced metastatic cancer, it is mandatory to destroy the ‘immunity’ of the cancer. Destruction of cancer immunity is most important particularly in the early stages of cancer when the immune system still functions well, so that there is no need to support it.
Stimulation of function of T-lymphocytes does not decrease the activity of immunosuppressive products released by cancer.
Common feature of immune reactivity in pregnancy, and in cancer, is the presence of characteristic sensitization to embryo antigens and inhibition of such reaction by serum. While endogenous immunosuppression serves to protect the embryo in pregnancy, such suppression supports the pathological process in cancer by distorting the effector immunity. Without eliminating such immunosuppression it is difficult to inhibit the growth of malignant tumor.
Anti-immunosuppression effect can be achieved by implantation of cells with a high concentration of blocking substances, found for example in cytotrophoblastic cells of chorionic villi, a homogenous epithelium with frequent mitoses, relatively poorly differentiated, developing before syncytiotrophoblast, a layer with rare mitoses, and a lack of MHC antigen. Cytotrophoblasts effectively block all reactions of cell immunity. Implantation of cytotrophoblastic cells triggers the production of anti-suppressive antibodies by B-cells of cancer patient, which neutralize many embryo-like products of cancer cells. Such antibodies form complexes with serum blocking factors, immunosuppressive agents fixed on circulating lymphocytes and tumor cells. The complexes of anti-suppressive antibodies and serum blocking substances are eliminated from the organism, and that arms the effector lymphocytes of the patient. Neutralization of the suppressor products on the surface of cancer cells makes them more vulnerable targets for NK cells and cytotoxic lymphocytes.
Implantation of cytotrophoblastic cells causes a direct anti-cancer effect. By weakening the protective mechanisms of cancer, or tumor immunity, the host’s effector immunity realizes its anti-tumor potential with less difficulty. The greatest de-blocking effect is due to antibodies against humoral suppressor products, antibodies against suppressor lymphocytes, and activation of counter-suppressors.
Autonomous nervous system regulation guided by bio-impedance / conductance is the third key component of ‘Drs. V.N.M. Integrative Individualized Cancer Treatment Project.
Western medicine has always directed its scientific interest to the matter, and ignored the study of energy in the living body. On the contrary, the eastern medicine has devoted for several millenia its full attention to the investigation of energy, and to the correction of abnormal flows of energy by various therapeutic methods, in particular acupuncture.
In the course of 20th century western physicists elucidated the nature of energy, and its relationship to the matter, but paradoxically this knowledge has had no influence on the official medical thinking in the West.
We now now that space and time is one continuous thing, and that the matter can be instantly changed into energy and reverse. Particles of the matter are actually waves of energy that behave as particles under certain conditions.
When we compare any living body 30 seconds before death and thirty seconds after death, there will be a dramatic difference in energy flows. The easily detectable energy in the body before death disappears at the moment of death.. Energy flow is obviously a cardinal feature of life. Lawyers recognized that but not so physicians. Determination of the moment of death by medical examination, in other words by observation of the matter, is frequently very difficult, and for that reason in most western legal systems the death is defined as an absence of brain waves, or absence of any detectable energy flow in the brain.
Energy flow in the living body
‘Eastern’ medicine has always believed that bio-energy, or vital energy, or Chi of Chinese medicine, control all physical processes in the living body, and that abnormalities of energy flow precede any observable pathological changes in the matter by days, months, even years.
Since official ‘western’ medicine accepted (‘eastern’) Chinese acupuncture more than three decades ago, it is about time to acknowledge the discoveries of ‘western’ non-linear physics, which serve as the basis of ‘quantum medicine’ (such technical term is still largely unknown but it clearly indicates the association with ‘quantum theory’ of modern physics).
One of the key discoveries of quantum medicine was that each higher living organism reacts to electromagnetic quanta specific for each individual, and resonates with a frequency that is characteristic for that organism. Such electromagnetic signals (quanta) are transmitted within a living organism as polarized waves, along the high-molecular conductive chains (peptide networks with hydrogen bridge links), which coincide with the meridians of Chinese acupuncture.
Technological advances after WW2 made it possible to measure very weak electric currents and to prove the validity of over two thousand years’ old Chinese theory of acupuncture which states that there is a continuous flow of bio-energy along the meridians. The resistance and conductance of the energy flow along these meridians can be measured at their end points, and at the specific points along their course, wherever they run close to the skin surface. These ‘acupuncture points’ can be identified by acupuncture needle, but more reliably, by direct or alternating currents, and stimulated. Such stimulation by application of test DC (direct current) or AC (alternating current) along various meridians allows to measure bio-energetic conditions of the whole system, and from such data to establish a diagnosis of the pathological condition of a patient, and ultimately to alleviate the diagnosed abnormality by appropriate electric therapy of the regulatory mechanisms, which in turn control all biochemical functions.
According to Chinese medical thought the initial phases of illness are associated with imbalance of energy flows between yin and yang, first in general, next within a particular meridian, then in the following phase regulatory functions disintegrate, and subsequently a malfunction of involved organ(s) becomes apparent. The structural damage of the involved organs is evident after some time only, which can be days, weeks, months, or years. Only at that point will western medicine recognize such a disorder as a disease. In other words, an abnormal energy flow means an impairment of function leading after a period of time to a disease, but when the energy flow is normalized, or ‘balanced’, the state of health is re-established.. When toxins, or various pathologic deposits, cause interference with, or interruptions of, polarized waves, electric therapy will re-establish a normal flow, and thereby correct mechanisms responsible for control of faulty biochemical processes.
The ability to measure weak electric currents after WW2 caused a replacement of acupuncture in 50-ies and 60-ies by electro-acupuncture, which also eliminated the need for the piercing of skin. The next stage of technological development brought us a computerized electro-acupuncture.
Every acupuncture point that demonstrates abnormal bio-energy flow can be treated by applying to it AC of saw-tooth waveform of ultra low frequency ~10Hz. The effect of such one time ‘short term therapy’ will last several hours. Ideally the electro-acupuncture treatment should be carried out at least twice a day. In the end, the repeated electro-acupuncture treatments will succeed in breaking the vicious cycle of the disease, stop its progress, so that body’s self-healing powers can take over, and the twice a day repetition of electro-acupuncture therapy will no longer be necessary, just the occasional maintenance treatment .
Besides limiting errors on the part of acupuncturist, and assuring reproducibility of measurements, computerized electro-acupuncture allows instant statistical manipulation of data, and thereby a dynamic, continuous in time, diagnosis, as well as the therapy, of large segments of the body, or of the control mechanism of the entire organ system. The degree of sophistication or complexity is almost unlimited, so that eventually data become comprehensible only to the computer, and not to the treating physician lacking a high level computer expertise.
All bio-resonance instruments work in the following way. After their attachment to the patient’s body via surface electrode, they take a set of electric measurements, and process them in order to establish an electromagnetic & electric diagnosis. Next, they treat the patient by electromagnetic energy with characteristics calculated and designed by the instrument itself to correct the imbalance of bio-energetic flows of the patient and thereby treat and ultimately cure the illness.
Bio-resonance equipment development has been based on the progress of the computer science. The newer computers permitted an instant processing of a huge quantity of data and a prompt response to them. Newer generations of bio-resonance instruments could take and process measurements from a quarter of the body, or an entire body, at the same time, while the classic electro-acupuncture apparatus could take bio-energy measurements on one meridian only at a time.
Bio-resonance diagnostic and therapeutic instruments enable individual determination of the frequencies of DNA molecules, and other resonators, required for the therapy of a particular patient. Each patient has his/ her own resonance spectrum, so that each patient can be treated only by an individually designed bio-energy therapy.
Most of research and development in electromagnetic medicine has been carried out by technical professionals, or by a few physicians possessing adequate technical background. Since medical professionals have been almost completely excluded from this process due to lack of understanding of technical science, and these bio-energetical instruments, once attached to the patient, perform completely independently, without a need for human control, physicians have been reluctant to use them.
Cell Physiology of Cancer Treatment & Cancer Reversal with Micro-current
Electromagnetic medicine sees human beings as networks of complex energy fields that interface with cellular systems. It uses specialized forms of energy , such as electrical energy, to positively affect those energetic systems that are out of balance due to a disease with a goal to restore homeostasis and equilibrium of autonomous nervous system by rebalancing the energy fields and energetic dynamics of the organism. This is all based on Einstein’s theory ‘E=mc²’ and a proof that energy and matter are dual expressions of the same universal substance.
In "Bioelectronics: A Study in Cellular Regulation, Defense, and Cancer," Nobel Prize winner A. v.Szent-Gyorgy postulated that the cell is a machine driven by energy. He stated that the living system may be permeated by an ‘invisible fluid’, the particles of which are electrons, that carry energy, charge and information, and act as the fuel of life. These electrons help to connect molecules to appropriate cell structures.
A.v. Szent-Gyorgy believed that the problem with cancer is not that cells are replicating by themselves, because replication is natural. The abnormality could be within faulty bio-electronic switching mechanisms, which cannot turn off the replicating process when necessary.
Other internal structures, such as mitochondria with their electron transport chains, can be viewed as tiny batteries or electrical power sources as well. The implication is that there may be electronic switching and transmission systems within cells and between them.
Guyton in his classic “Textbook of Medical Physiology” described the cell membrane as a capacitor. He stated that the alignment of electrical charges on two sides of the cell membrane is exactly the same process that takes place when an electrical capacitor becomes charged with electricity. Structure of the cell membrane as the bi-molecular leaflet of phospholipids and sterols with hydrocarbon interior and polar groups at the surface has been proven for years.
With A. v.Szent-Gyorgy's idea in mind, Becker postulated an analog-coded information system that was closely related to the nerves, located in glial and Schwann cells, i.e. not located in the nerve fibers themselves, which used semi-conductive direct currents and that, either alone or in synchrony with the nerve impulse system, regulated growth, healing, and other basic processes essential for maintaining health..
Becker's most astonishing discovery was that, under the influence of an appropriately applied direct current of the more primitive analog system, in the micro-ampere range, certain cells are capable of dedifferentiation. In frogs, mature, fully differentiated cells are able to retrogress to an embryonic form, and then re-differentiate into whatever cell types are needed for complete regeneration.
Humans have limited powers of regeneration because our bodies favor a highly developed digital nervous system of alternating currents, which allows greater abilities of complex motor skills and a conscious thought.
Micro-currents more closely match the analog systems of the body. If indeed it is the primitive DC systems of the body that modulate healing, this may offer an explanation for the documented healing acceleration effects of micro-current treatment.
Over 60 years ago, at the same time that R.Voll published his measurements of weak currents along the Chinese meridians, anatomist R. Burr stated: “The Universe in which we find ourselves and from which we cannot be separated is a place of Law and Order. It is not an accident, nor chaos. It is organized and maintained by an ‘Electro-dynamic field’ capable of determining the position and movement of all charged particles. All living things are molded and controlled by electro-dynamic fields that can be measured and mapped with standard voltmeters. These ‘L-fields of life’ are the basic blueprints of all life on this planet. Measurements of these voltages can reveal physical and mental conditions, thereby allow diagnose illness before symptoms develop, and treat it early.“
An interference field is a local tissue irritation with the potential to cause destabilization of the autonomous nervous system either locally or systemically. Such fields can be found in almost any part of the body.
The purpose of appropriate electric therapy is to eliminate the effect of all interference fields so that the autonomous nervous system of the whole body is restored to a condition of balance as close as possible, continuously for 5 years, until cancer can be declared cured.
The balance of autonomous nervous system means the same as the balance of the bio-energetic flow along the Chinese meridians, i.e. status of health as perfect as possible in the patient with incurable or no longer treatable disease, e.g. cancer.
Autonomous Nervous System Regulation Therapy Guided By Computational (Artificial) Intelligence
Electrical resistance of the tissue with pathology is higher than that of the immediately surrounding area, which can be either normal or lesser pathological. Regeneration is a series of endothermic electrochemical reactions: electricity, in miniscule quantities, is needed by the cells to provide energy to fuel the regenerative process.
Diseased organ, organ system or tissue needs energy in the form of electricity for healing and repair. The patients' body contains more than a sufficient quantity of energy to produce the desired effect. Unfortunately, the electrical resistance in pathological area is so high that the body's energy flow will not enter the area because the primary laws of physics require that energy travel only via the path of least resistance.
As a result, the electrical energy traveling in the body will circumvent the area of pathology. It will always take the path of leas t resistance, which is around, rather than through, the area of disease, e.g. cancer. To get therapeutic effect we must enable the energy to pass into the area of pathology while still obeying these laws. We can do this by increasing the body's ability to actually produce and store energy in the diseased area.
This is done by charging the tissue like a battery. Tissue cells, just like battery cells, have the ability to hold an electrical charge. The greater the charge on the cell, the less resistant it is to the flow of electrical energy. As the cell charge increases, the molecular kinetic energy in the cell increases. The electro-vibratory rate of the cell's molecular structure must increase with the increased kinetic energy (energy of movement).
An increased electro-vibratory rate will be coupled in direct proportion with an increased electro-conductivity, i.e. decreased electrical resistance. While functioning as a battery, the charged cell provides some of the energy which is involved in the energy flow equation. In other words, the addition of electrical energy to an area of pathology increases the electrical conductivity of the area and hence allows the body's own energy to enter the area and regenerate the tissue.
Term for quantity of charge that a cell can maintain is ‘capacitance’. As the general health of the cell improves, the capacitance increases. Biologically, capacitance of the cell is directly proportional to the concentration of adenosinetriphosphate (ATP) in the cell. ATP is at least partially responsible for binding electrons, which cumulatively represent the electrical charge and usable energy of the cell.
ATP concentration serves a direct vital function in the active transport mechanism known as the ‘sodium pump’. Active transport means that this system, which is directly responsible for the trans-membrane movement of sodium, potassium, calcium, metabolic waste and metabolites, requires large amounts of energy to move vital ions in and out of the cell. Metabolic waste builds up in toxic concentrations when the cell respiration is not proper. The energy which is released when ATP breaks down to ADP fuels the reactions which establish balanced membrane potential gradients and which bring vital metabolites into the cell in exchange for metabolic wastes which are dumped into the general circulation to be detoxified and excreted. What we have when the sodium pump is not functioning is a hypo-polarized, toxic, starving cell.
Cells low in energy, lacking conductance across the cell membrane, are susceptible to cancer and all other incurable and untreatable diseases. Metastases are more likely to occur in tissues lacking conductance. Normal conductance across cell membrane allows the voltage sensitive ion channels to function appropriately and maintain homeostasis.
Two German scientists Erwin Neher and Bert Sakmann received Nobel Prize in Medicine and Physiology for elucidating the function of ‘single ion channels’ of cells in 1991.
Re-establishment of the sodium pump occurs when the increase in intracellular current increases mitochondrial function. The increased electro-vibratory rate of the mitochondria enhances the production of ATP in the cytoplasm. The ATP provides the fuel for the transmigration of metabolites and metabolic waste across the cell membrane as well as the reestablishment of cellular ionic concentration gradients. What this means is that cell membrane potential, normally 0.85mV in healthy tissue, is reestablished, levels of intracellular metabolic waste, i.e. lactic acid, are reduced and fresh concentrations of usable metabolites are introduced into the exhausted cell. At this point the cell can enter its repair & regenerative phase, with tissue regeneration functions re-established.
It is well known that the calcium concentration within the cell plays a significant role. Calcium ions open cell membrane channels, enter the intra-cellular fluid in order to increase their concentration there. Cell physiologists recognized that stimuli which activate the most energy-requiring processes within cell do so via an increase in intracellular calcium. An increase in intracellular calcium following membrane depolarization occurs because: (1) voltage sensitive calcium channels allow extra-cellular calcium to enter, (2) current entering the cell can cause calcium release from cell organelles.
Investigations of living cells based on electrical concepts and using electrical techniques have been amazingly successful. The electrical parameters of cell metabolism are well known and include: resting potential, capacitance, resistance, conductance, impedance, polarization capacity, current density, inductive reactance and electrical phase angle, to name a few.
Ionic current flow pattern between normal and damaged tissue plays an important role in stimulating plasma membrane repair processes, essential for the restoration of tha t tissue to a normal functional state. The rates at which these processes occur may be accelerated by judicious imposition of an electric current from an outside source.
Current that does eventually enter a cell alters the cell membranes voltage in such a way that it allows influx of ions, which can turn on and accelerate biochemical processes, essential to cell repair. With direct current only used, the intracellular current would flow only through discrete pores or ion-channels, through a low resistance pathway called tight junctions. If we use pulsed current, there will be an additional pathway for current to enter a cell through membrane capacitance. Current flow through this additional pathway increases the ratio of intracellular to extra-cellular current flow, making the current more effective.
Alternating current of saw-tooth waveform with a rapid voltage rise-time is more effective because: (1) pulsed voltage must rise to its maximum value before membrane capacitance has had time to ‘charge up’, (2) voltage sensitive Na and Ca channels stay open only 0.5 milliseconds, and they don't re-open for a brief time following closure, i.e. stimulus pulse needs to stay on long enough for cell membrane capacitance to charge to its maximum value before the pulse turns off.
R. Voll was able to chart specific frequencies in the range 0.5 – 10.0 Hz that had pronounced effects on different tissues. This very low frequency range, which is resonant with the normal electrical activity of the human body and the frequency of the earth, is the main domain of modern micro-current therapy.
Basic bio-physical research within the last decades has led to the development of autonomous nervous system therapy guided by bio-cybernetics (bio-equivalent stimulation) in the USA, used for treatment of patients since the beginning of 1980’s. The concept is based on the realization that the bio-physical processes that promote the cell metabolism in humans play a significant role in the regulation of all vital processes.
The bio-stimulation is a vectored motion of carriers of electrical charge or so-called micro currents. It is better tolerated than any other form of stimulation and can gently treat tissue and cells. This current is fine-tuned to the level of the normal electric activities of the somatic cells and therefore very natural and effective. Electric voltages of between 10 and 20 mV are normal for the cell membranes of a healthy cell. This is maintained by the energy consuming proton transport at the semi-permeable cell membrane. If disorders of membranes of the cell occur, it also influences the protein and energy metabolism of the cell and leads to disorders of all these physiological processes of the cell.
The biological stimulation effect with electric therapy begins where the body’s own immune system and repair function fail.
The healing process of damaged tissue is shortened with externally applied bio-equivalent stimulation that speeds up the repair or renewal of such damaged cells. This occurs by increasing the ATP production, protein synthesis, and DNA regeneration.
Bio-equivalent stimulation normalizes the usual activities between the cells, if they have been damaged. The external application of bio-electrical therapy promotes the production of ATP, protein synthesis, oxygen saturation, ion-exchange, food absorption, breakdown of toxins and neutralization of the oscillatory polarity of defective cells.
Without energy there is no life. A healthy organism can only function, if it is provided with sufficient energy in the correct form and dosage. Oorganism and cells, its building blocks, cells, represent an open system that, as such, can receive, transform and release energy.
The energy of food is transformed into ATP. During the ATP breakdown, this energy is released again and drives all reactions in the organism. From a thermo-dynamic point, this expenditure of energy creates order in the cells and in the entire body. If this order cannot be maintained in parts of the body or in its entirety, a disease will evolve.
The immune system and repair functions are generally capable of energetic self-direction when it comes to their energetic needs. If this is not the case, the body requires help from outside.
Autonomic nervous system regulation therapy guided by bio-cybernetics
‘Cybernetics constitute the science of control and information, irrespective of whether we are dealing with living organisms or machines.’ (N Wiener, father of Cybernetics, 1948).
Cybernetics are about 'the control and automatic regulation of interlinked and intermeshed processes at a minimum cost in terms of the amount of energy used', without which life would not be possible. Medicine must concern itself like no other discipline with the biological control circuits in the living organism, yet, this new line of thought is only beginning to make a little headway in medicine, and do so very slowly.
Organic structures work by means of control circuits that have evolved and proved themselves over millions of years. Control systems are the systems that respond to and affect internal and external environment of a man. Their dysfunction is a cause of every disease, e.g. cancer. Cybernetics regard man as the most highly developed of all self-regulating dynamic systems in existence. In man, the principle of linear causality (i.e. the straight-line relationship between cause and effect), no longer applies. Instead, the principle applicable to man is that of an intermeshed interactive causality. In any cybernetic system, every subsystem is continuously linked to every other subsystem in a network of reciprocal relationships. Seen in this light, a disease is a cybernetic problem, since it is the result of a disturbance of the regulatory functions within the interacting structure of the self-regulating dynamic system that is man, and is due to malfunctions in the transmission and processing of information between individual control circuits within the overall system. Thus, it ought to be the physician's task to act upon these disturbed or faulty control systems, in particular when cancer is the disease to be handled.
That’s why it is one of the three key components of Drs. V.N.M. Integrative Individualized Cancer Treatment project.
Immune deficiency disorders, such as AIDS, chronic weakness syndrome, as well as cancer, and autoimmune diseases, have been a menace of modern medicine, not only because there is no known cure, but also because the modern medicine found no effective way to slow down the progress of such illnesses.
During the last few years there has been a growing body of peer-reviewed publications reporting on the success of fetal precursor cell transplantation in the treatment of many cancers, both solid, and dispersed. So perhaps the scientific fact that fetal precursor cell transplantation is by far the most potent immuno-stimulant known to medicine today stops being one of the 'best kept secrets'. Immune system testing is still not sufficiently sensitive to assess the degree of benefit of the immuno-stimulating effect of fetal precursor cell transplants.
Modern medicine has a very limited armamentarium of therapies for immune deficiencies. With exception of fetal precursor cell transplants there are no effective direct immuno-stimulants available for treatment. Fetal precursor cell transplantation stimulates immune system spectacularly well, particularly one that is weakened for one reason or another. And that applies to even such deadly diseases of immune system as AIDS, and cancer, in which the immune system is malfunctioning as a result of an illness and a method of treatment used to combat it.
It is therapeutically effective also against autoimmune diseases, apparently functioning as an immuno-modulator in a way that lacks a scientific explanation.
The survival of a live organism without a defense against harmful factors of the outer and inner world, whether living or non-living, is impossible. The defense mechanism that has developed since the inception of life millions of years ago is a complicated and highly organized system which protects the biologic existence of every living being. Contact with, and defense against, the environment are key properties of life. Intake and metabolism of life-sustaining matters are recognized as fundamental biological features, but the defense against damaging and life-threatening matters is on the same level of importance.
As sophisticated as the immune system is, it operates on a very simple basic principle. It distinguishes 'self' from 'non-self' and attacks 'non-self' with the ultimate goal of removing it from the body. Usually this works in our favor, such as when our body is attacked by pathogenic microbes. At other times it works against us, such as when our life depends on a transplanted organ: heart, liver or kidney, and our immune system attacks it as 'non-self' and causes its rejection. Sometimes the immune system fails to recognize even parts of our own body as 'self' and attacks them as 'non-self', and an autoimmune disease develops.
Immune system defends body against microorganisms, and macromolecules recognized as ‘foreign’, by non-specific inborn, and associated with it specific acquired, or adaptive, immunity. Parts of microorganisms and ‘foreign’ macromolecules behave as ‘antigens’, and specific acquired immune system reacts to them by activation and multiplication of mono-specific T- and B-lymphocytes. Both B- and T-lymphocytes have receptors on their surface for detection of foreign antigens that specifically enable their activities, and production of cytokines, low-molecule soluble polypeptides, and their secretion into the surrounding extracellular space, that participate in elimination of the ‘non-self’ cells or macromolecules by non-specific mechanisms..
The lymphocytes are the most important cells of our defense system. More than a trillion of them are in the body at once, either circulating in the blood or on guard in the lymph nodes. There are two types of lymphocytes: T-cells and B-cells. Both are formed in bone marrow. B-cells mature in blood, while T-cells must pass through and mature in thymus gland. Thymus instructs the lymphocytes how to recognize 'non-self' and what to do when 'non-self' invades the body.
B-lymphocytes differentiate after stimulation by an antigen into plasma cells, which produce and secrete into body fluids antibodies, i.e. immunoglobulins IgA, IgD, IgE, IgG, IgM, that react with antigens that triggered their differentiation, neutralize or opsonize antigen, and activate complement system, i.e. humoral immunity. They do not enter live cells. Every B-lymphocyte is programmed to produce one specific antibody. This system has a memory. Once a B-cell produced an antibody against a specific foreign antigen, it remembers it forever. Thus each succeeding wave of the same infection, or the same antigen, is fought off with an increasing efficiency. This is the basis for immunization and explains why we fall victim to several childhood infectious diseases only once. The 'immunological memory' works sometimes in the opposite direction, i.e. in allergic conditions, ranging from hay fever to sudden death due to anaphylactic shock.
T-lymphocytes are the sentries of our body. When the ‘non-self’ antigen is recognized, they ‘sound an alarm’ and direct cooperation of different cells of immune system, including histiocytes, macrophages, etc., and various non-cellular components, i.e. complement, cytokines, etc., and directly attack somatic cells infected by virus, or that turned malignant, and cause a rejection of tissue transplants, i.e. cell immunity. T-cells are divided into T-helpers, responsible for co-activation of B-lymphocytes and thereby production of antibodies, supporters of function of NK-cells, and T- cytotoxic/ suppressors, responsible for uncovering and destruction of virus infected cells.
Any antigen is ‘remembered’ by T- and B-memory cells. From lymphoid precursor cells without any receptors, develops during their ‘upbringing period’ in thymus for T-cells, and in bone marrow for B-cells, a repertoire of about 108 of various types of lymphocytes, that are mono-specific, i.e. directed against one specific antigen. Such ‘virgin’ lymphocytes circulate in the body, between blood, peripheral lymphatic tissue, lymph, and blood again. When such ‘virgin’ lymphocyte meets ‘its’ antigen, usually within lymphatic tissues, it multiplies, passes through clonal selection and proliferation, and a large number of mono-specific daughter cells is produced. These daughter cells differentiate into required T-cells, or B-cells, which eventually eliminate antigen.
‘Virgin’ lymphocyte with receptors against own body tissues is eliminated in thymus, i.e. T-cells, or in bone marrow, i.e. B-cells, early enough after recognition of ‘its’ antigen. Such ‘clonal deletion’ creates in this way a ‘central immunological tolerance’. This recognition of difference between foreign antigens and antigens of own body is ‘learned’ by immune system at the moment of birth. All substances that come in contact with immune system at that moment are recognized for the rest of life as ‘own’ and all others that come in contact with immune system later on as ‘foreign’. If this recognition fails, an autoimmune disease develops.
Immune system cells are characterized by their own system of membrane antigens, which appear in cell membrane at certain stage of development, remain there for a certain period of time, or up until cell death. These membrane antigens are known as clusters of differentiation (CD). Some CD are located on both T- and B-lymphocytes, others are specific for some cells only.
The defense capabilities of immune system have a 'life profile'. After 'immuno-tolerance' of the embryonic and fetal stage of life, when the immune system is not functioning and the entire defense depends on the immune system of pregnant mother and placenta, the immune system gradually 'wakes up', until it reaches the optimal functioning level between 10 and 15 years of age. During puberty the immune system function gets depressed, the exact timing depends on the sex.
Afterward the immune system works at full capacity for the next 30 to 35 years.
Between 40 and 50 years of age a regression period begins, when the function of immune system decreases relentlessly until a senile 'immuno-paralysis' period is reached when body becomes defenseless against malignancy and even the most banal infections.